| |
| |
|
| Insider
Information: |
Milligan John F |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,574,306 |
|
|
Indirect Shares
|
211,755 |
|
|
| Direct
Value |
$101,180,647 |
|
|
|
Indirect Value
|
$7,182,494 |
|
|
| Total
Shares |
1,786,061 |
|
|
| Total
Value |
$108,363,140 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
President and CEO, Dir... |
2018-11-27 |
1,574,306 |
2012-01-06 |
111,755 |
Premium* |
|
|
4d Molecular Therapeutics Inc. |
FDMT |
Director |
2020-12-15 |
0 |
2020-12-15 |
100,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
159 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2017-02-16 |
4 |
D |
$70.31 |
$589,831 |
D/D |
(8,389) |
1,065,924 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2011-03-15 |
4 |
D |
$39.79 |
$417,477 |
D/D |
(10,492) |
204,284 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2003-08-07 |
4 |
OE |
$5.72 |
$144,157 |
D/D |
11,000 |
49,656 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2003-08-07 |
4 |
S |
$63.21 |
$695,930 |
D/D |
(11,000) |
44,012 |
|
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2012-10-29 |
4 |
OE |
$8.94 |
$99,977 |
D/D |
11,180 |
270,187 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2011-03-15 |
4/A |
D |
$39.79 |
$501,434 |
D/D |
(12,602) |
206,674 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
COO and CFO |
• – – |
2008-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
227,893 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
256,281 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2017-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
15,035 |
1,074,313 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2012-03-12 |
4 |
D |
$46.16 |
$759,609 |
D/D |
(16,456) |
239,480 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-12-24 |
4 |
OE |
$3.70 |
$80,050 |
D/D |
17,748 |
268,102 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2005-02-25 |
4 |
S |
$35.28 |
$705,675 |
D/D |
(20,000) |
92,302 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2005-02-25 |
4 |
OE |
$11.76 |
$235,158 |
D/D |
20,000 |
112,302 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2007-02-22 |
4 |
S |
$73.59 |
$1,472,251 |
D/D |
(20,000) |
103,301 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2007-02-22 |
4 |
OE |
$7.40 |
$186,998 |
D/D |
20,000 |
123,301 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2008-12-19 |
4 |
OE |
$3.70 |
$80,548 |
D/D |
20,000 |
242,281 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2004-10-27 |
4 |
OE |
$7.41 |
$162,939 |
D/D |
22,000 |
111,596 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2004-10-27 |
4 |
S |
$34.50 |
$759,005 |
D/D |
(22,000) |
89,596 |
|
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2011-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
214,776 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2013-03-06 |
4 |
D |
$45.40 |
$1,160,787 |
D/D |
(25,568) |
564,774 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2013-11-25 |
4 |
OE |
$7.63 |
$199,954 |
D/D |
25,588 |
590,362 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
COO and CFO |
• – – |
2007-06-04 |
4 |
AS |
$82.35 |
$2,150,678 |
D/D |
(26,100) |
107,201 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2011-03-15 |
4/A |
A |
$0.00 |
$0 |
D/D |
27,000 |
219,276 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2010-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
296,102 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2005-11-18 |
4 |
S |
$54.34 |
$1,610,338 |
D/D |
(29,600) |
93,021 |
|
- |
|
159 Records found
|
|
Page 2 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
